A Double-Blind Randomized Placebo Controlled Trial of Magnesium Oxide for Alleviation of Chronic Low Back Pain
Uniformed Services University Of The Health Sciences Bethesda United States
Pagination or Media Count:
This double-blind randomized placebo controlled trial used a pre-testpost-test control group design. Sixty adults patients complaining of chronic low back pain greater than six months were recruited from a free standing major metropolitan pain center. Half of the patients received an oral 800mg magnesium oxide supplement and half received anoral placebo every day for a two-month trial period. Laboratory analysis of serum total magnesium, serum ionized magnesium, and sublingual tissue magnesium levels Exatest, ICD Inc. were performed before and after the trial. All patients were asked to assess their pain and various quality of life indicators using a 10 point Likert Scale before and after the trial.